Literature DB >> 24477745

(18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker.

Luca Bertolaccini1, Andrea Viti, Eleonora Lanzi, Mirella Fortunato, Stephane Chauvie, Andrea Bianchi, Alberto Terzi.   

Abstract

INTRODUCTION: (18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography is not yet accepted as a standard pretreatment evaluation of thymic epithelial neoplasm (TEN). Statistical correlation between standardized uptake value of tumor/mediastinum ratio and patients' WHO risk class has been reported. PET metabolic tumor volume (MTV) and total glycolytic volume (TGV) have been reported as additional prognostic imaging biomarkers in several human tumors. Purpose of study was to establish whether MTV and TGV add prognostic information in TEN.
MATERIALS AND METHODS: A retrospective dynamic cohort study of prospectively collected data (2006-2012) on 23 consecutive patients with pathologically proven TEN (no thymic carcinoma) was conducted. All patients underwent chest CT, and PET for staging. SUV T/M ratio, semi-quantitative and volumetric analyses of TEN were calculated. Patients were categorized according to WHO classification (low-risk and high-risk thymomas). Statistical analysis was performed with bootstrap method. Multi-collinearity was established using Pearson correlation coefficient. Cut-off point for TGV was compared using Mantel Cox log rank test.
RESULTS: SUV T/M ratio, MTV, and TGV correlate with low- and high-risk TEN. However, the statistical correlation between TGV and WHO classification (ρ = 0.897) was higher than SUV T/M ratio (ρ = 0.873). Since sample distributions were not uniformly smooth, only one cut-off value was identified: a TGV of 383 served as a cut-off value between low-risk and high-risk TEN.
CONCLUSION: TGV is a PET reproducible imaging marker in patients with TEN, provides prognostic information, and could be useful in pretreatment stratification of patients. Nevertheless, it needs validation in larger cohort studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477745     DOI: 10.1007/s11748-014-0374-1

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  21 in total

1.  Prognostic value of 18F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: comparisons of volume-based metabolic parameters.

Authors:  Seung Hwan Moon; Joon Young Choi; Hwan Joo Lee; Young-Ik Son; Chung-Hwan Baek; Yong Chan Ahn; Keunchil Park; Kyung-Han Lee; Byung-Tae Kim
Journal:  Head Neck       Date:  2012-02-06       Impact factor: 3.147

2.  Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.

Authors:  Matthias Miederer; Stefan Seidl; Andreas Buck; Klemens Scheidhauer; Hans-Jürgen Wester; Markus Schwaiger; Aurel Perren
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-20       Impact factor: 9.236

3.  Impact of the definition of peak standardized uptake value on quantification of treatment response.

Authors:  Matt Vanderhoek; Scott B Perlman; Robert Jeraj
Journal:  J Nucl Med       Date:  2012-01       Impact factor: 10.057

Review 4.  Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.

Authors:  Christine Haie-Meder; Richard Pötter; Erik Van Limbergen; Edith Briot; Marisol De Brabandere; Johannes Dimopoulos; Isabelle Dumas; Taran Paulsen Hellebust; Christian Kirisits; Stefan Lang; Sabine Muschitz; Juliana Nevinson; An Nulens; Peter Petrow; Natascha Wachter-Gerstner
Journal:  Radiother Oncol       Date:  2005-03       Impact factor: 6.280

5.  18F-FDG uptake on PET helps predict outcome and response after treatment in unresectable thymic epithelial tumors.

Authors:  Kyoichi Kaira; Haruyasu Murakami; Satoru Miura; Rieko Kaira; Hiroaki Akamatsu; Madoka Kimura; Akira Ono; Asuka Tsuya; Yukiko Nakamura; Tateaki Naito; Toshiaki Takahashi; Masahiro Endo; Nobuyuki Yamamoto
Journal:  Ann Nucl Med       Date:  2010-12-21       Impact factor: 2.668

Review 6.  Spectrum of thymic uptake at 18F-FDG PET.

Authors:  Brett Ferdinand; Pramod Gupta; Elissa L Kramer
Journal:  Radiographics       Date:  2004 Nov-Dec       Impact factor: 5.333

7.  Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.

Authors:  Hatem El-Bawab; Abdul Aziz Al-Sugair; Mohammed Rafay; Wassem Hajjar; Mohammed Mahdy; Khaled Al-Kattan
Journal:  Eur J Cardiothorac Surg       Date:  2007-02-09       Impact factor: 4.191

8.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

Review 9.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

10.  18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma.

Authors:  Hidekatsu Shibata; Hiroaki Nomori; Kimiichi Uno; Kazuya Sakaguchi; Rumi Nakashima; Kenichi Iyama; Katsumi Tomiyoshi; Masahiro Kaji; Tomoyuki Goya; Takashi Suzuki; Hirotoshi Horio
Journal:  Cancer       Date:  2009-06-01       Impact factor: 6.860

View more
  3 in total

1.  Usefulness of Preoperative 18F-FDG PET/CT for Patients with Thymic Epithelial Tumors.

Authors:  Mana Ishibashi; Yoshio Tanabe; Hiroto Yunaga; Hidenao Miyoshi; Ken Miwa; Hiroshige Nakamura; Shinya Fujii; Toshihide Ogawa
Journal:  Yonago Acta Med       Date:  2019-03-28       Impact factor: 1.641

2.  High throughput tools to access images from clinical archives for research.

Authors:  Shawn N Murphy; Christopher Herrick; Yanbing Wang; Taowei David Wang; Darren Sack; Katherine P Andriole; Jesse Wei; Nathaniel Reynolds; Wendy Plesniak; Bruce R Rosen; Steven Pieper; Randy L Gollub
Journal:  J Digit Imaging       Date:  2015-04       Impact factor: 4.056

Review 3.  Current Roles of PET/CT in Thymic Epithelial Tumours: Which Evidences and Which Prospects? A Pictorial Review.

Authors:  Filippo Lococo; Marco Chiappetta; Elizabeth Katherine Anna Triumbari; Jessica Evangelista; Maria Teresa Congedo; Daniele Antonio Pizzuto; Debora Brascia; Giuseppe Marulli; Salvatore Annunziata; Stefano Margaritora
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.